Lonza Potelligent CHOK1SV host cell line

Friday, 20 November, 2009 | Supplied by: Capsugel Australia Pty Ltd

Potelligent CHOK1SV, a host cell line for manufacturing recombinant antibodies, combines BioWa’s glycosylation Potelligent technology with Lonza’s GS Gene Expression System and CHOK1SV.

The cell line retains the features of a high-productivity cell line (robust, high-yielding, scalable) and the bioprocess platform for CHOK1SV is repeatable in the new cell line.

Antibodies produced by the new cell line: exhibit enhanced antibody dependent cellular cytotoxicity (ADCC) even with the low-ADCC allotype of CD16, overcoming CD16 polymorphism; can exert potent cytotoxic effects when their target antigen is low; work in whole blood; and retain required features of antibodies, such as Protein A binding.

Online: www.capsugel.com
Phone: 1300 657508
Related Products

Cayman Chemical Cell Death Screening Library

Cayman Chemical's Cell Death Screening Library consists of two plates and contains...

GeneTex circadian rhythm antibodies

Circadian rhythms are physical, behavioural and mental changes that respond primarily to the...

Enzo Life Sciences SCREEN-WELL Cardiotoxicity Library

The SCREEN-WELL Cardiotoxicity Library from Enzo Life Sciences is a focused collection of 130...

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd